Entry Point Capital, LLC Quanterix Corp Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
A detailed history of Entry Point Capital, LLC transactions in Quanterix Corp stock. As of the latest transaction made, Entry Point Capital, LLC holds 720 shares of QTRX stock, worth $9,619. This represents 0.01% of its overall portfolio holdings.
Number of Shares
720Holding current value
$9,619% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding QTRX
# of Institutions
158Shares Held
32.1MCall Options Held
39KPut Options Held
5.5K-
Alliancebernstein L.P. New York, NY3.41MShares$45.6 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.14MShares$41.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.04MShares$27.3 Million0.0% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.92MShares$25.6 Million2.24% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.31MShares$17.5 Million0.0% of portfolio
About Quanterix Corp
- Ticker QTRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,987,600
- Market Cap $494M
- Description
- Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...